A股異動 | 匯納科技(300609.SZ)放量大跌近14% 股價創2年新低
格隆匯12月7日丨匯納科技(300609.SZ)跌幅擴大至13.65%,報23.92元創2年新低價,成交額放出歷史天量,大幅成交1.76億元,總市值20.16億元。股價自8月以來持續下跌,累計跌幅超45%,持續刷新階段新低價。匯納科技今日有2018.04萬股限售股解禁,佔公司總股本的16.55%。近期股價本就弱勢,今日解禁再遭大跌。值得一提的是,匯納科技11月初擬回購3000萬元-6000萬元股份,但股價並未有明顯回彈。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.